Agios Pharm Revenue Per Share Over Time

Stocks . USA . 
Stock . Agios Pharm
AGIO Stock  USD 57.51  1.83  3.29%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Agios Pharm Performance and Agios Pharm Correlation.
To learn how to invest in Agios Stock, please use our How to Invest in Agios Pharm guide.
  
As of the 26th of November 2024, Revenue Per Share is likely to drop to 0.46.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agios Pharm. If investors know Agios will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agios Pharm listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
11.66
Revenue Per Share
0.582
Quarterly Revenue Growth
0.212
Return On Assets
(0.18)
Return On Equity
0.5366
The market value of Agios Pharm is measured differently than its book value, which is the value of Agios that is recorded on the company's balance sheet. Investors also form their own opinion of Agios Pharm's value that differs from its market value or its book value, called intrinsic value, which is Agios Pharm's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agios Pharm's market value can be influenced by many factors that don't directly affect Agios Pharm's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Agios Pharm's value and its price as these two are different measures arrived at by different means. Investors typically determine if Agios Pharm is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agios Pharm's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:
Apply

Cross Equities Revenue Per Share Analysis

Compare Agios Pharm and related stocks such as Mereo BioPharma Group, Blueprint Medicines Corp, and Day One Biopharmaceu Revenue Per Share Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity
201020112012201320142015201620172018201920202021202220232024
MREO(0.0476)(0.0476)(0.0476)(0.0476)(0.0476)(0.0476)(0.0476)(0.0476)(0.0014)(0.0014)0.00120.06910.00250.01520.0159
BPMC0.62520.62520.62520.62520.62520.62521.01020.56691.01491.390614.55493.07733.4214.1182.65
DAWN0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
BMRN0.05343.93644.16333.98165.15765.5616.72867.53128.4229.517710.289910.097111.313712.879613.52
IDYA0.79030.79030.79030.79030.79030.79030.79030.79030.79030.79030.79030.79261.22890.40660.39
ANAB0.09380.09380.09380.09381.1191.24140.91880.50550.20270.29572.74712.30310.36520.63720.76
MGTX0.40080.40080.40080.40080.40080.40080.40080.40080.40080.40080.41250.85410.35240.24810.5
KROS1.12591.12591.12591.12591.12591.12591.12591.12591.12591.12590.86140.86140.00510.00590.0056
KYMR0.06590.06590.06590.06590.06590.06590.06590.06590.06590.06591.96171.51770.86821.34650.92
RVMD0.55290.55290.55290.55290.55290.55290.55290.55290.55290.84810.64540.40370.43880.10230.0972
CCCC1.30941.30941.30941.30941.30941.30941.30941.30941.30940.49740.77090.99440.63640.41810.4
NRIX2.32512.32512.32512.32512.32512.32512.32512.32510.8011.1370.69350.79471.41681.631.31
RLAY1.93931.93931.93931.93931.93931.93931.93931.93931.93931.93931.93930.03180.01230.20840.2
STOK0.31890.31890.31890.31890.31890.31890.31890.31890.31890.31890.31890.31890.31890.19960.29
PLRX1.60481.60481.60481.60481.60481.60481.60481.60481.60481.60481.17620.21120.23050.02690.0256
BDTX0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
ARVN0.3730.3730.3730.3730.3730.3730.3730.36561.52011.30520.55150.9342.46991.41440.9
SNDX0.03610.03610.03610.03610.03610.03610.08340.10040.05980.04980.03672.68342.68342.422.54
COGT0.510.510.510.510.510.511.08531.13031.5642.95260.71030.71030.71030.641.06
CGEM0.42770.42770.42770.42770.42770.42770.42770.42770.42770.42770.42770.42770.42770.380.34
KALV0.44720.44722.1220.57261.54140.44720.15480.81321.06940.7150.66461.54141.54141.770.99
MRSN0.59220.59220.59220.59220.59220.59221.43891.45930.460.97060.01356.0E-40.28380.31740.3

Agios Pharm and related stocks such as Mereo BioPharma Group, Blueprint Medicines Corp, and Day One Biopharmaceu Revenue Per Share description

The amount of revenue generated by a company per share of stock, calculated by dividing total revenue by the average number of shares outstanding.

My Equities

My Current Equities and Potential Positions

View AllNext
Agios Pharm
AGIO
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
LocationMassachusetts; U.S.A
ExchangeNASDAQ Exchange
USD 57.51
When determining whether Agios Pharm offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Agios Pharm's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Agios Pharm Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Agios Pharm Stock:
How To Invest In Agios
Details
Is Agios Stock a good investment?
Details
What is Agios Pharm's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out Agios Pharm Performance and Agios Pharm Correlation.
To learn how to invest in Agios Stock, please use our How to Invest in Agios Pharm guide.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Agios Pharm technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Overlap Analysis
View
Forecast Models
View
Price Shifting
View
Volatility Indicators
View
Value Movement
View
A focus of Agios Pharm technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Agios Pharm trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY